Ruminations of a Taco-Obsessed Philly Native

Amicus Therapeutics is not your average pharmaceutical company. It is a biopharmaceutical company that uses biologically generated drug treatment therapies to heal a person’s body. Biological components taken from blood, vaccines, gene therapies and bodily tissue process account for some of the primary biopharmaceutical treatments that are utilized by Amicus Therapeutics (https://www.google.com/finance?cid=706165).

The thing that separates this organization form other pharmaceutical companies is their focus on the elimination of rare and orphan diseases. While they are not the only company that works to eliminate these conditions; this organization is leading the way in this field.

Amicus Therapeutics came into existence in 2002. They were founded by various venture companies that pooled their resources together to make the company a viable operation. The venture companies that founded Amicus consisted of Radius Ventures, Canaan Partners and New Enterprise Associates.

Orphan and rare diseases are not common but they still have the potential damage many people’s lives. Both of these disease types affect a small percentage of a population. They are also genetically based conditions. The researchers at Amicus develop their biopharmaceutical products to ensure that affected people have a fighting chance at recovering or managing their disease.

The company generates $18 million a year in revenues (Yahoo Fincace) and it is a public organization. Amicus Therapeutics uses its own patented biopharmaceutical products to provide healing that patients need. Chaperone-Advanced Replacement Therapy or CHART is a specialized enzyme replacement therapy. It is a proven biopharmaceutical product.

John Crowley is the company’s CEO. He currently leads the organization at levels operation. Bradley Campbell is the Chief Operating Officer and the CFO is William Baird. These three men were chosen to run Amicus Therapeutics because of their biopharmaceutical knowledge and business acumen. Many people with rare and orphan diseases have been treated by Amicus Therapeutics. This organization continues to provide high quality care and solutions to some of the world’s toughest diseases.
Visit Amicus Therapeutics @ Twitter

The Antique Wine Company (often abbreviated as just “AWC”) is a large global company that specializes in spirits and wines. The luxury merchant was created over three decades ago (in 1982) by Stephen Williams, who to this very day works as its CEO. The company is based out of Marylebone, which is a bustling section of Central London, England. The Antique Wine Company also has two sales branches located in Asia.

The Antique Wine Company provides spirits and wines to the international wine trade. They also provide spirits and wines to individual consumers, dining establishments and hotels all around the planet. They have 2,000 plus customers in 70 nations.

Most of The Antique Wine Company’s products are contemporary vintages. Despite the merchant’s strong enthusiasm for antique vintage wines, one of their main goals is to sell wines that possess the potential to develop into tomorrow’s antiques. At The Antique Wine Company, the aim is to trade spirits and wines that are extraordinary, regardless of age. The company presently has more than 10,000 bottles of the globe’s highest quality vintage wines secure in their cellars.

Not only does the company serve as a source for uncommon and high quality wines, but they also offer services such as cellar planning, wine storage, cellar management, cellar design and wine master courses. The Antique Wine Company is globally renowned for their fine wine expertise and vast knowledge.

The Antique Wine Company made the news in the summer of 2011 when they traded a particularly valuable bottle of wine. They sold a white wine bottle that had the distinction of having the highest value traded in history. It was a Chateau d’Yquem bottle from 1811. The purchaser was Christian Vanneque, a wine lover who used to work as a sommelier (wine steward). He paid the hefty price of 75,000 GBP (Great British pounds) for the bottle. This equates to approximately $123,000 United States dollars.

The AWC sells a large selection of wines from all over Europe and the New World. Their available European wines come from Bordeaux, France, the Loire Valley, France and areas of Spain and Italy, for example. They also sell New World offerings from the United States, New Zealand and Australia.